Inhalable Measles Vaccine Seen as Treatment Boon

Aktiv-Dry was featured on CBS news.  Please click the link below to see the article.

CBS News - Inhalable Measles Article

Aktiv-Dry Selected for a $19.5 Million Grant from the Foundation for the National Institutes of Health
Aktiv-Dry Awarded Research Grant to Explore Inhalable siRNA Dry Powder Targeting RSV

NY Times December 6, 2005, D. McNeil Jr.